Recruiting

Additional Effects of Pilates Breathing and Diaphragmatic Breathing Combined With Moderate Intensity Continuous Treadmill Training on Blood Pressure, Chest Expansion, Pulmonary Function and Quality Of Life in Pre-hypertensive Patients

Pre-hypertension is defined as systolic blood pressure between 120-139mmHg or diastolic blood pressure between 80-89mmHg and is considered a risk factor for developing hypertension. Early lifestyle interventions such as aerobic exercise and breathing techniques may help prevent progression to hypertension. This randomised controlled trial aims to determine the additional effects of pilates breathing and diaphragmatic breathing combined with moderate-intensity continuous treadmill training on blood pressure, chest…

ClinicalTrials.gov IDNCT07529821
PhaseNA
Enrollment45
SponsorFoundation University Islamabad
Age20 Years
SexALL
I'm interested View official listing

Conditions studied

PRE-HYPERTENSION

About this study

Pre-hypertension is defined as systolic blood pressure between 120-139mmHg or diastolic blood pressure between 80-89mmHg and is considered a risk factor for developing hypertension. Early lifestyle interventions such as aerobic exercise and breathing techniques may help prevent progression to hypertension. This randomised controlled trial aims to determine the additional effects of pilates breathing and diaphragmatic breathing combined with moderate-intensity continuous treadmill training on blood pressure, chest expansion, pulmonary function and quality of life in pre-hypertensive patients. A total of 45 participants will be randomly allocated into three groups: treadmill training with pilates breathing, tredmill training with diaphragmtic brething and treadmill training alone. The intervention will be conducted for 6 weeks. Outcome measures including blood pressure, pulmonary function, chest expansion and quality of life will be assesed before and after the intervention.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Prehypertensive individuals (SBP 120-139 mmHg or DBP 80-89 mmHg) * Age 20-55 years * Both male and female * Sedentary individuals according to IPAQ * Willing to participate and provide informed consent Exclusion Criteria: * Diagnosed hypertension (≥140/90 mmHg) * Cardiopulmonary diseases (COPD, asthma, CAD, heart failure) * Musculoskeletal conditions preventing exercise * Neurological disorders * Pregnancy * Participation in structured exercise in last 3 months

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.